Article Text

Download PDFPDF

Complex abdominal wall reconstruction for an isolated parietal recurrence of ovarian cancer
  1. Manel Montesinos-Albert1,
  2. Pierre-Antoine Giroux2,
  3. Delphine Hudry2,
  4. Camille Pasquesoone3,
  5. Fabrice Narducci2 and
  6. Carlos Martinez-Gomez2
  1. 1Department of Obstetrics and Gynecology, University Hospital La Fe, Valencia, Spain
  2. 2Department of Surgical Oncology, Oscar Lambret Cancer Centre, Lille, France
  3. 3Department of Pathology, Oscar Lambret Cancer Centre, Lille, France
  1. Correspondence to Dr Carlos Martinez-Gomez, Department of Surgical Oncology, Oscar Lambret Center, Lille 5900, France; c-martinezgomez{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Abdominal wall involvement in gynecological malignancies can present a surgical challenge, particularly when primary fascia closure is not possible. To reduce the risk of post-operative hernia, there are several options available to restore abdominal wall integrity such as synthetic mesh, biological mesh, muscular flaps, and fasciocutaneous flaps. These options can be used depending on the specific circumstances and requirements of the patient.

In an active oncologic context, biological meshes and autologous flaps are often preferred over synthetic meshes for abdominal wall reconstruction. This is because biological meshes and autologous flaps carry a lower risk of mesh infection, exposure, and colonization by tumor cells.1 Additionally, they can provide satisfactory long-term functional outcomes.2 Therefore, when planning abdominal wall reconstruction, it is important to consider factors such as the extent of the resection, the risk of post-operative complications, and any planned adjuvant treatments. This pre-operative planning helps ensure the most appropriate choice for abdominal wall reconstruction in the given oncologic context.

We present a case of a patient who was treated for endometrioid ovarian cancer FIGO stage IIIC in 2017 and experienced an isolated abdominal wall relapse in December 2022. The patient underwent a surgical resection with en-bloc full-thickness parietal resection,3 and the abdominal wall Figure 1 reconstruction was planned using a biological mesh fixed to the rectus abdominis, covered by a pedicled anterolateral thigh fasciocutaneous flap.4 The patient was discharged on the 10th post-operative day. The anatomopathological analysis revealed a low-grade endometrioid adenocarcinoma with tumor-free surgical margins (Video 1). On the 30th post-operative day the patient experienced an infected lymphocele of the thigh, which was successfully managed with percutaneous drainage and antibiotics. No mesh removal was required, and adjuvant chemotherapy was started within the sixth post-operative week. This case emphasizes the importance of tailored reconstruction in abdominal wall resections. It highlights the potential benefits of using a combined approach involving biological meshes and autologous flaps to achieve satisfactory functional, oncologic, and cosmetic outcomes while minimizing the post-operative risks and delays in adjuvant treatments.

Figure 1

Surgical aspect after wall resection, mesh fixation and flap harvesting.

Video 1 Full-thickness parietal resection followed by combined abdominal wall reconstruction.

Data availability statement

All data relevant to the study are included in the article.

Ethics statements

Patient consent for publication

Ethics approval

The patient involved in our research provided oral consent for the publication and filming, and we took great care to ensure the patient’s identity was preserved at all times, thus maintaining their anonymity. The study did not require IRB approval as it was not an interventional study and no experimental procedures were conducted on the patient. The participant gave informed consent to participate in the study before taking part.


The authors acknowledge the patient presented in this case study; the medical and paramedical staff of Oscar Lambret Center; and the Department of Gynecologic Oncology of La Fe University Hospital.



  • Twitter @MMontesinos_Alb

  • Contributors MM-A: Conceptualization, video editing, writing - original draft. P-AG: Conceptualization, project administration, supervision, surgery and writing – review. DH, CP, FN: Conceptualization, project administration, supervision, writing - review. CM-G: Conceptualization, project administration, surgery, video recording, supervision, writing - review and guarantor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.